$HROW Income Statement | Understand Stock

$HROW

$28.94 -$0.02 (0.05%) Live

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product Sales Net
Other Revenues
Total revenues
Cost of sales
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
Impairment of long-lived assets
Total operating expenses
Income from operations
Other (expense) income:
Equity in losses of unconsolidated entities
Interest expense, net
Investment (loss) gain from Eton Pharmaceuticals
Eton Pharmaceuticals
Total investment (loss) gain from Eton Pharmaceuticals

Gain on forgiveness of PPP loan
Gain on sale of non-ophthalmology assets
Loss on extinguishment of debt
Other income (expense), net
Total other expense, net

Loss before income taxes
Income tax expense
Total net loss including noncontrolling interests
Net loss
Preferred dividends and accretion of preferred stock issuance costs
Net loss attributable to common stockholders
Basic and diluted net loss per share of common stock
Weighted average number of shares of common stock outstanding, basic and diluted
Basic net loss per share of common stock
Diluted net loss per share of common stock
Weighted average number of shares of common stock outstanding, basic
Weighted average number of shares of common stock outstanding, diluted

Comments